David MacDonald

4.8k total citations · 1 hit paper
105 papers, 2.8k citations indexed

About

David MacDonald is a scholar working on Pathology and Forensic Medicine, Surgery and Oncology. According to data from OpenAlex, David MacDonald has authored 105 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pathology and Forensic Medicine, 37 papers in Surgery and 32 papers in Oncology. Recurrent topics in David MacDonald's work include Lymphoma Diagnosis and Treatment (45 papers), Chronic Lymphocytic Leukemia Research (23 papers) and Orthopaedic implants and arthroplasty (19 papers). David MacDonald is often cited by papers focused on Lymphoma Diagnosis and Treatment (45 papers), Chronic Lymphocytic Leukemia Research (23 papers) and Orthopaedic implants and arthroplasty (19 papers). David MacDonald collaborates with scholars based in Canada, United States and United Kingdom. David MacDonald's co-authors include R. M. Smith, A. Furlong, P.V. Giannoudis, P. de Boer, S. J. Matthews, Peter V. Giannoudis, Richard van der Jagt, David Simpson, Ian W. Flinn and John M. Burke and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

David MacDonald

104 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study

2014 419 citations Ian W. Flinn, Richard van der Jagt et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David MacDonald Canada	27	1.1k	977	904	622	484	105	2.8k
Roberto S Oliveri Denmark	20	366 0.3×	612 0.6×	459 0.5×	745 1.2×	157 0.3×	33	2.0k
Masashi Miyazaki Japan	27	1.1k 1.0×	1.3k 1.4×	196 0.2×	94 0.2×	148 0.3×	140	2.4k
S. Delanian France	31	228 0.2×	1.4k 1.4×	1.3k 1.5×	208 0.3×	347 0.7×	82	4.6k
Shinobu Nakamura Japan	28	297 0.3×	400 0.4×	427 0.5×	142 0.2×	278 0.6×	114	2.2k
Sheldon S. Lin United States	36	335 0.3×	1.5k 1.5×	210 0.2×	206 0.3×	579 1.2×	112	3.7k
Niloo M. Edwards United States	36	225 0.2×	3.7k 3.8×	296 0.3×	1.1k 1.7×	404 0.8×	126	5.6k
Brian C. Cooley United States	39	179 0.2×	2.0k 2.1×	284 0.3×	599 1.0×	482 1.0×	151	5.0k
Shmuel Fuchs Israel	33	227 0.2×	2.6k 2.7×	244 0.3×	1.4k 2.3×	325 0.7×	110	5.7k
Abeel A. Mangi United States	29	325 0.3×	2.2k 2.2×	123 0.1×	881 1.4×	665 1.4×	105	3.9k
Ranjith Babu United States	26	510 0.5×	803 0.8×	61 0.1×	377 0.6×	410 0.8×	51	1.9k

Countries citing papers authored by David MacDonald

Since Specialization

Citations

This map shows the geographic impact of David MacDonald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David MacDonald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David MacDonald more than expected).

Fields of papers citing papers by David MacDonald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David MacDonald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David MacDonald. The network helps show where David MacDonald may publish in the future.

Co-authorship network of co-authors of David MacDonald

This figure shows the co-authorship network connecting the top 25 collaborators of David MacDonald. A scholar is included among the top collaborators of David MacDonald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David MacDonald. David MacDonald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bartlett, Nancy L., Uwe Hahn, Won Seog Kim, et al.. (2025). Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology. 43(9). 1061–1072. 7 indexed citations

Berinstein, Neil L., Kees-Peter de Roos, Rebecca F. McClure, et al.. (2023). Indolent lymphoma: Bendamustine, rituximab and acalabrutinib in Waldenstroms Macroglobulinemia (BRAWM). Hematological Oncology. 41(S2). 396–397. 1 indexed citations

Kahl, Brad S., John M. Burke, Richard van der Jagt, et al.. (2017). Assessment of Maintenance Rituximab after First-Line Bendamustine-Rituximab in Patients with Follicular Lymphoma: An Analysis from the BRIGHT Trial. Blood. 130. 484–484. 10 indexed citations

Ogura, Michinori, Kensei Tobinai, Kiyohiko Hatake, et al.. (2016). Phase I Study of Inotuzumab Ozogamicin Combined with R-CVP for Relapsed/Refractory CD22+ B-cell Non-Hodgkin Lymphoma. Clinical Cancer Research. 22(19). 4807–4816. 28 indexed citations

Kuruvilla, John, David MacDonald, C. Tom Kouroukis, et al.. (2015). Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12. Blood. 126(6). 733–738. 28 indexed citations

Burke, John M., Ian W. Flinn, Michael Craig, et al.. (2015). Effect of bendamustine in combination with rituximab on QT interval duration in patients with advanced de novo indolent non-Hodgkin or mantle cell lymphoma. Cancer Chemotherapy and Pharmacology. 76(1). 211–216. 1 indexed citations

Flinn, Ian W., Richard van der Jagt, Brad S. Kahl, et al.. (2014). Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study. Blood. 123(19). 2944–2952. 419 indexed citations breakdown →

White, Darrell, Nizar J. Bahlis, Andrew R. Belch, et al.. (2012). Lenalidomide Plus Melphalan Without Prednisone for Previously Untreated Older Patients With Multiple Myeloma: A Phase II Trial. Clinical Lymphoma Myeloma & Leukemia. 13(1). 19–24. 2 indexed citations

Buckstein, Rena, John Kuruvilla, Neil Chua, et al.. (2011). Sunitinib in relapsed or refractory diffuse large B-cell lymphoma: a clinical and pharmacodynamic phase II multicenter study of the NCIC Clinical Trials Group. Leukemia & lymphoma. 52(5). 833–841. 14 indexed citations

10.

Levesque, Nadja, et al.. (2008). Health Management Program: Factors Influencing Completion of Therapy with High-Dose Interferon Alfa-2b for High-Risk Melanoma. Current Oncology. 15(1). 36–41. 15 indexed citations

11.

Allami, M.K., et al.. (2005). Thoracolumbar spinal injuries following speedboat accidents. Injury Extra. 36(11). 511–516. 4 indexed citations

12.

Giannoudis, Peter V., et al.. (2005). Knee Dislocation With Ipsilateral Femoral Shaft Fracture. Journal of Orthopaedic Trauma. 19(3). 205–210. 7 indexed citations

13.

Giannoudis, Peter V., A. Hinsche, Andrew J. Cohen, et al.. (2003). Segmental tibial fractures: an assessment of procedures in 27 cases. Injury. 34(10). 756–762. 44 indexed citations

14.

Clark, Charles R., et al.. (2001). Posterior-Stabilized and Cruciate-Retaining Total Knee Replacement. Clinical Orthopaedics and Related Research. 392(392). 208–212. 82 indexed citations

15.

Giannoudis, P.V., et al.. (2000). Nonunion of the femoral diaphysis. Journal of Bone and Joint Surgery - British Volume. 82-B(5). 655–658. 154 indexed citations

16.

MacDonald, David. (1998). (i) Risks versus rewards of total hip replacement. Current Orthopaedics. 12(4). 229–231. 1 indexed citations

17.

MacDonald, David, et al.. (1997). Thromboprophylaxis in lower limb arthroplasty surgery: A review. Current Orthopaedics. 11(1). 19–23. 1 indexed citations

18.

MacDonald, David. (1995). (iii) The infected joint replacement: Prevention, diagnosis and treatment. Current Orthopaedics. 9(1). 21–27. 2 indexed citations

19.

MacDonald, David, et al.. (1992). Styrene migration from general-purpose and high-impact polystyrene into food-simulating solvents. Food and Chemical Toxicology. 30(3). 225–232. 46 indexed citations

20.

Chandler, Redonna, et al.. (1988). Establishing and Evaluating an Industrial Social Work Programme:. Employee Assistance Quarterly. 3(3-4). 243–253. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact